Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
FLNB Gene Spondylocarpotarsal synostosis syndrome NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
FLNB Gene Atelosteogenesis type 1 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
FLNB Gene Atelosteogenesis type 3 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
FLNB Gene Larsen syndrome NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
FLNB - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 5 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 498 | 498 |
|
Centogene AG - the Rare Disease Company Germany | 499 | 499 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Invitae Connective Tissue Disorders Panel Invitae United States | 195 | 92 |
|
Invitae Skeletal Disorders Panel Invitae United States | 624 | 349 |
|
Desbuquois dysplasia and related disorders Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 3 | 11 |
|
Desbuquois dysplasia and related disorders Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 3 | 11 |
|
Desbuquois dysplasia and related disorders NGS panel HNL Genomics Connective Tissue Gene Tests United States | 3 | 11 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Atelosteogenesis, type III, 108721, Autosomal dominant; AO3 (Atelosteogenesis type III) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Boomerang dysplasia, 112310, Autosomal dominant (Boomerang dysplasia) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.